Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells

Shuyuan Yeh, Hiroshi Miyamoto, Kazuo Nishimura, Hongyo Kang, John Ludlow, Peiwen Hsiao, Chihuei Wang, Chingyuan Su, Chawnshang Chang

Research output: Contribution to journalArticle

Abstract

The retinoblastoma protein may function as a tumor suppressor by controlling the progression of the normal cell cycle. Inactivation of Rb has been regarded as an important event in prostate carcinogenesis. However, the detailed mechanism of how Rb is linked to androgen-androgen receptor (A-AR), the major factor in promotion of prostate tumor growth, remains unclear. Using GST-Rb pull down assay and mammalian two-hybrid system, we report here that Rb can bind specifically to AR in an androgen-independent manner. Transient transfection assay demonstrates that cotransfection of AR and Rb can further induce AR transcriptional activity 4-fold in the presence of 1 nM dihydrotestosterone in DU145 cells. Interestingly, cotransfection of Rb and ARA70, the first identified AR coactivator, with AR can additively induce AR transcriptional activity 13-fold (from 5-fold to 64-fold). In conclusion, our discovery that Rb can function as a coactivator to induce AR transcriptional activity in prostate cells may represent the first data to link a negative growth regulatory protein function in a positive manner, by inducing the transcriptional activity of AR.

Original languageEnglish (US)
Pages (from-to)361-367
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume248
Issue number2
DOIs
StatePublished - Jul 20 1998
Externally publishedYes

Fingerprint

Retinoblastoma
Androgen Receptors
Androgens
Tumors
Prostate
Assays
Prostatic Neoplasms
Retinoblastoma Protein
Dihydrotestosterone
Hybrid systems
Neoplasms
Two-Hybrid System Techniques
Cells
Growth
Transfection
Cell Cycle
Carcinogenesis
Proteins
human AR protein

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. / Yeh, Shuyuan; Miyamoto, Hiroshi; Nishimura, Kazuo; Kang, Hongyo; Ludlow, John; Hsiao, Peiwen; Wang, Chihuei; Su, Chingyuan; Chang, Chawnshang.

In: Biochemical and Biophysical Research Communications, Vol. 248, No. 2, 20.07.1998, p. 361-367.

Research output: Contribution to journalArticle

Yeh, Shuyuan ; Miyamoto, Hiroshi ; Nishimura, Kazuo ; Kang, Hongyo ; Ludlow, John ; Hsiao, Peiwen ; Wang, Chihuei ; Su, Chingyuan ; Chang, Chawnshang. / Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. In: Biochemical and Biophysical Research Communications. 1998 ; Vol. 248, No. 2. pp. 361-367.
@article{a857db5233044330a3108bac3dc44b46,
title = "Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells",
abstract = "The retinoblastoma protein may function as a tumor suppressor by controlling the progression of the normal cell cycle. Inactivation of Rb has been regarded as an important event in prostate carcinogenesis. However, the detailed mechanism of how Rb is linked to androgen-androgen receptor (A-AR), the major factor in promotion of prostate tumor growth, remains unclear. Using GST-Rb pull down assay and mammalian two-hybrid system, we report here that Rb can bind specifically to AR in an androgen-independent manner. Transient transfection assay demonstrates that cotransfection of AR and Rb can further induce AR transcriptional activity 4-fold in the presence of 1 nM dihydrotestosterone in DU145 cells. Interestingly, cotransfection of Rb and ARA70, the first identified AR coactivator, with AR can additively induce AR transcriptional activity 13-fold (from 5-fold to 64-fold). In conclusion, our discovery that Rb can function as a coactivator to induce AR transcriptional activity in prostate cells may represent the first data to link a negative growth regulatory protein function in a positive manner, by inducing the transcriptional activity of AR.",
author = "Shuyuan Yeh and Hiroshi Miyamoto and Kazuo Nishimura and Hongyo Kang and John Ludlow and Peiwen Hsiao and Chihuei Wang and Chingyuan Su and Chawnshang Chang",
year = "1998",
month = "7",
day = "20",
doi = "10.1006/bbrc.1998.8974",
language = "English (US)",
volume = "248",
pages = "361--367",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells

AU - Yeh, Shuyuan

AU - Miyamoto, Hiroshi

AU - Nishimura, Kazuo

AU - Kang, Hongyo

AU - Ludlow, John

AU - Hsiao, Peiwen

AU - Wang, Chihuei

AU - Su, Chingyuan

AU - Chang, Chawnshang

PY - 1998/7/20

Y1 - 1998/7/20

N2 - The retinoblastoma protein may function as a tumor suppressor by controlling the progression of the normal cell cycle. Inactivation of Rb has been regarded as an important event in prostate carcinogenesis. However, the detailed mechanism of how Rb is linked to androgen-androgen receptor (A-AR), the major factor in promotion of prostate tumor growth, remains unclear. Using GST-Rb pull down assay and mammalian two-hybrid system, we report here that Rb can bind specifically to AR in an androgen-independent manner. Transient transfection assay demonstrates that cotransfection of AR and Rb can further induce AR transcriptional activity 4-fold in the presence of 1 nM dihydrotestosterone in DU145 cells. Interestingly, cotransfection of Rb and ARA70, the first identified AR coactivator, with AR can additively induce AR transcriptional activity 13-fold (from 5-fold to 64-fold). In conclusion, our discovery that Rb can function as a coactivator to induce AR transcriptional activity in prostate cells may represent the first data to link a negative growth regulatory protein function in a positive manner, by inducing the transcriptional activity of AR.

AB - The retinoblastoma protein may function as a tumor suppressor by controlling the progression of the normal cell cycle. Inactivation of Rb has been regarded as an important event in prostate carcinogenesis. However, the detailed mechanism of how Rb is linked to androgen-androgen receptor (A-AR), the major factor in promotion of prostate tumor growth, remains unclear. Using GST-Rb pull down assay and mammalian two-hybrid system, we report here that Rb can bind specifically to AR in an androgen-independent manner. Transient transfection assay demonstrates that cotransfection of AR and Rb can further induce AR transcriptional activity 4-fold in the presence of 1 nM dihydrotestosterone in DU145 cells. Interestingly, cotransfection of Rb and ARA70, the first identified AR coactivator, with AR can additively induce AR transcriptional activity 13-fold (from 5-fold to 64-fold). In conclusion, our discovery that Rb can function as a coactivator to induce AR transcriptional activity in prostate cells may represent the first data to link a negative growth regulatory protein function in a positive manner, by inducing the transcriptional activity of AR.

UR - http://www.scopus.com/inward/record.url?scp=0032551749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032551749&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1998.8974

DO - 10.1006/bbrc.1998.8974

M3 - Article

C2 - 9675141

AN - SCOPUS:0032551749

VL - 248

SP - 361

EP - 367

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -